- Home
- MQ vs ARQT Comparison
MQ vs ARQT Comparison
Compare MQ & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQ
- ARQT
- Stock Information
- Founded
- MQ 2010
- ARQT 2016
- Country
- MQ United States
- ARQT United States
- Employees
- MQ N/A
- ARQT N/A
- Industry
- MQ Computer Software: Prepackaged Software
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- MQ Technology
- ARQT Health Care
- Exchange
- MQ Nasdaq
- ARQT Nasdaq
- Market Cap
- MQ 1.9B
- ARQT 1.7B
- IPO Year
- MQ 2021
- ARQT 2020
- Fundamental
- Price
- MQ $5.56
- ARQT $13.79
- Analyst Decision
- MQ Hold
- ARQT Strong Buy
- Analyst Count
- MQ 13
- ARQT 6
- Target Price
- MQ $4.95
- ARQT $18.80
- AVG Volume (30 Days)
- MQ 7.9M
- ARQT 2.0M
- Earning Date
- MQ 08-06-2025
- ARQT 08-13-2025
- Dividend Yield
- MQ N/A
- ARQT N/A
- EPS Growth
- MQ N/A
- ARQT N/A
- EPS
- MQ 0.11
- ARQT N/A
- Revenue
- MQ $528,100,000.00
- ARQT $212,819,000.00
- Revenue This Year
- MQ $19.30
- ARQT $61.15
- Revenue Next Year
- MQ $21.97
- ARQT $37.98
- P/E Ratio
- MQ $51.48
- ARQT N/A
- Revenue Growth
- MQ N/A
- ARQT 100.03
- 52 Week Low
- MQ $3.37
- ARQT $7.64
- 52 Week High
- MQ $6.00
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- MQ 65.37
- ARQT 51.03
- Support Level
- MQ $5.48
- ARQT $12.97
- Resistance Level
- MQ $5.66
- ARQT $13.84
- Average True Range (ATR)
- MQ 0.16
- ARQT 0.60
- MACD
- MQ -0.03
- ARQT 0.02
- Stochastic Oscillator
- MQ 78.10
- ARQT 52.82
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.